Nk-1 receptor antagonists for the treatment of symptoms of...

Details Nk-1 receptor antagonists for the treatment of symptoms of... Nk-1 receptor antagonists for the treatment of symptoms of...

A - Human Necessities

61

K

A61K 31/395 (2006.01) A61K 31/38 (2006.01) A61K 31/40 (2006.01) A61K 31/41 (2006.01) A61K 31/439 (2006.01) A61K 31/44 (2006.01) A61K 31/445 (2006.01)

Patent

CA 2235438

Abstract The present invention relates to a pharmaceutical composition for treating or preventing symptoms of irritable bowel syndrome in a mammal, including a human, comprising a compound that is an NK-1 receptor antagonist, in particular a substance P receptor antagonist, together with a pharmaceutically acceptable diluent or carrier.

La présente invention concerne une composition pharmaceutique destinée au traitement ou à la prévention des symptômes du syndrome du côlon irritable chez les mammifères, y compris les humains, comprenant un composé qui est un antagoniste des récepteurs de NK-1, et plus particulièrement un antagoniste des récepteurs de la substance P, ainsi qu'un diluant ou un transporteur acceptable sur le plan pharmaceutique.

Affiliated with

Also associated with

Rating

Nk-1 receptor antagonists for the treatment of symptoms of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nk-1 receptor antagonists for the treatment of symptoms of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nk-1 receptor antagonists for the treatment of symptoms of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1512449